Tadalafil vs Sildenafil
Both are PDE5 inhibitors with the same fundamental mechanism. Tadalafil acts longer and supports daily-dose continuity. Sildenafil acts faster with a shorter active window and is typically used on demand. Selection is provider-reviewed against cardiovascular history, current medications, lifestyle, and continuity preference.
Tadalafil is typically the provider-reviewed choice when timing flexibility, daily-dose continuity, or longer active window are priorities.
Explore pathwaySildenafil is typically the provider-reviewed choice when on-demand, event-timed dosing is preferred and the patient does not need a continuous active window.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Do tadalafil and sildenafil address the underlying cause of ED?
No — both support vascular response in the moment. Underlying endocrine or vascular root causes are evaluated separately through the optimization assessment.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment